Key stats
About HARVEST FUND MANAGEMENT SSE STAR BIOLOGY & MEDICINE INDEX ETF CN
Home page
Inception date
Dec 27, 2023
Structure
Open-Ended Fund
SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
Harvest Fund Management Co., Ltd.
ISIN
CNE100006BP8
Classification
Returns
1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
---|---|---|---|---|---|---|
Price performance | — | — | — | — | — | — |
NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
588700 assets under management is 264.07 M CNY. It's risen 4.81% over the last month.
588700 fund flows account for 174.12 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 588700 doesn't pay dividends to its holders.
588700 shares are issued by Harvest Fund Management Co., Ltd. under the brand Harvest. The ETF was launched on Dec 27, 2023, and its management style is Passive.
588700 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
588700 follows the SSE Science and Technology Innovation Board Biomedical Index Yield - CNY - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
588700 price has risen by 4.47% over the last month, and its yearly performance shows a 17.66% increase. See more dynamics on 588700 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 5.12% over the last month, showed a 8.07% increase in three-month performance and has increased by 16.34% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 5.12% over the last month, showed a 8.07% increase in three-month performance and has increased by 16.34% in a year.
588700 trades at a premium (0.23%) meaning the ETF is trading at a higher price than the calculated NAV.